Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively

Endocrinology

Volumn 146, Issue 12, 2005, Pages 5120-5127

  Neary, Nicola M ^a   Small, Caroline J ^a   Druce, Maralyn R ^a   Park, Adrian J ^a   Ellis, Sandra M ^a   Semjonous, Nina M ^a   Dakin, Catherine L ^a   Filipsson, Karin ^a   Wang, Fang ^a   Kent, Aysha S ^a   Frost, Gary S ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; PEPTIDE YY; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 (7 36); GLUCAGON-LIKE PEPTIDE 1 (7-36); PEPTIDE FRAGMENT; PEPTIDE YY (3 36); PEPTIDE YY (3-36);

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARCUATE NUCLEUS; ARTICLE; BRAIN STEM; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; FEMALE; FOOD INTAKE; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS; IMMUNOREACTIVITY; LEAN BODY WEIGHT; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; NAUSEA; NONHUMAN; NORMAL HUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DIABETES MELLITUS; DOSE RESPONSE; DRUG COMBINATION; DRUG POTENTIATION; EATING; FEEDING BEHAVIOR; GENETICS; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MOTOR ACTIVITY; OBESITY; PATHOPHYSIOLOGY; RAT;

ANIMALS; BEHAVIOR, ANIMAL; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG SYNERGISM; EATING; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; OBESITY; PEPTIDE FRAGMENTS; PEPTIDE YY; RATS;

EID: 27844508598     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0237     Document Type: Article

References (32)

1. Anini Y, Fu-Cheng X, Cuber JC, Kervran A, Chariot J, Roz C 1999 Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflugers Arch 438:299-306
2. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei, MA, Cone RD, Bloom SR 2002 Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650-654
3. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
4. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O'Rahilly S 2003 Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 311:915-919
5. Halatchev IG, Ellacott KL, Fan W, ConeRD2004 PYY3-36 inhibits food intake through a melanocortin-4 receptor-independent mechanism. Endocrinology 145:2585-2590
6. Rodriquez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gomez R, Munoz RM, Eng J, Blazquez E 2000 Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 49:709-717
7. Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR 2004 Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145:2687-2695
8. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM, Long SJ, Morgan LM, Holst JJ, Astrup A 2001 A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86:4382-4389
9. Szecowka J, Tatemoto K, Rajamaki G, Efendic S 1983 Effects of PYY and PP on endocrine pancreas. Acta Physiol Scand 119:123-126
10. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, Elmquist JK 2002 Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest 110:43-52
11. Sawchenko PE, Swanson LW 1982 The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 257:275-325
12. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR 2003 Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941-948
13. Wettergren A, Maina P, Boesby S, Holst JJ 1997 Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Scand J Gastroenterol 32:552-555
14. Gibbs J, Young RC, Smith GP 1973 Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84:488-495
15. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992
16. Lu XY, Shieh KR, Kabbaj M, Barsh GS, Akil H, Watson SJ 2002 Diurnal rhythm of agouti-related protein and its relation to corticosterone and food intake. Endocrinology 143:3905-3915
17. Lambert PD, Phillips PJ, Wilding JP, Bloom SR, Herbert J 1995 c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y. Brain Res 670:59-65
18. Paxinos GT, Watson C 1998 The rat brain in stereotactic co-ordinates. 4th ed. London: Academic Press
19. Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG, Stanley SA, Zollner AN, Ghatei MA, Bloom SR 2002 Hypothalamic actions of neuromedin U. Endocrinology 143:4227-4234
20. Cohen MA, Ellis SM, le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, Bloom SR 2003 Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88:4696-4701
21. Gutzwiller JP, Goke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, Winterhalder R, Conen D, Beglinger C 1999 Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 44:81-86
22. Flint A, Raben A, Blundell JE, Astrup A 2000 Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 24:38-48
23. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR 1985 Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070-1077
24. Kreymann B, Williams G, Ghatei MA, Bloom SR 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300-1304
25. Ghatei MA, Uttenthal LO, Christofides ND, Bryant MG, Bloom SR 1983 Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract. J Clin Endocrinol Metab 57:488-495
26. Batt RA 1983 Decreased food intake in response to cholecystokinin (pancreozymin) in wild-type and obese mice (genotype ob/ob). Int J Obes 7:25-29
27. Martin NM, Small CJ, Sajedi A, Patterson M, Ghatei MA, Bloom SR 2004 Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin. Int J Obes Relat Metab Disord 28:886-893
28. Dubuc PU, Wilden NJ, Carlisle HJ 1985 Fed and fasting thermoregulation in ob/ob mice. Ann Nutr Metab 29:358-365
29. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ 2001 The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 25(Suppl 5):S63-S67
30. Koda S, Date Y, Murakami N, Shimbara T, Hanada T, Toshinai K, Niijima A, Furuya M, Inomata N, Osuye K, Nakazato M 2005 The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146:2369-2375
31. Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL 2005 Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice. Endocrinology 146:3748-3756
32. Gutzwiller JP, Degen L, Matzinger D, Prestin S, Beglinger C 2004 Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. Am J Physiol Regul Integr Comp Physiol 287:R562-R567